Trials / Recruiting
RecruitingNCT05815784
Myopia Control: a Comparison Study Between Atropine and MiSight
Myopia Control in the Pediatric Population: a Comparison of MiSight, Naturalvue Multifocal, and Atropine 0.05%
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 348 (estimated)
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago · Academic / Other
- Sex
- All
- Age
- 5 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
This research project aims to provide additional knowledge of pharmacological and optical methods of myopia control and to gain a better understanding of the biometry of the pediatric eye, which contributes to the onset and progression of myopia. As a result, this study will improving our best practices for myopia control in pediatric patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atropine | 0.05% atropine. One drop per eye per day for 2 years. |
| DEVICE | MiSight contact lenses | Daily wear for 2 years. |
Timeline
- Start date
- 2023-05-02
- Primary completion
- 2026-03-13
- Completion
- 2026-03-13
- First posted
- 2023-04-18
- Last updated
- 2024-11-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05815784. Inclusion in this directory is not an endorsement.